Selected research
Industry Research
DXM and Codeine Syrup Industry Research Report 2026
Market perspective
The global DXM and Codeine Syrup market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for DXM and Codeine Syrup is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for DXM and Codeine Syrup is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for DXM and Codeine Syrup is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of DXM and Codeine Syrup include Atley Pharmaceuticals, Vertical Pharmaceuticals, Pfizer, Merck, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global DXM and Codeine Syrup market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DXM and Codeine Syrup Market by Company
Atley Pharmaceuticals
Vertical Pharmaceuticals
Pfizer
Merck
Novartis
Johnson & Johnson
DXM and Codeine Syrup Segment by Type
DXM
Promethazine-codeine Cough Syrup
DXM and Codeine Syrup Segment by Application
Adult
Children
DXM and Codeine Syrup Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DXM and Codeine Syrup market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DXM and Codeine Syrup and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DXM and Codeine Syrup.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of DXM and Codeine Syrup manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of DXM and Codeine Syrup by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of DXM and Codeine Syrup in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DXM
- Promethazine-codeine Cough Syrup
Applications
- Adult
- Children
Companies covered
- Atley Pharmaceuticals
- Vertical Pharmaceuticals
- Pfizer
- Merck
- Novartis
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global DXM and Codeine Syrup Market Size (2021-2032)
- 2.2.2 Global DXM and Codeine Syrup Sales (2021-2032)
- 2.2.3 Global DXM and Codeine Syrup Market Average Price (2021-2032)
- 2.3 DXM and Codeine Syrup by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DXM
- 2.3.3 Promethazine-codeine Cough Syrup
- 2.4 DXM and Codeine Syrup by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global DXM and Codeine Syrup Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global DXM and Codeine Syrup Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global DXM and Codeine Syrup Revenue of Manufacturers (2021-2026)
- 3.4 Global DXM and Codeine Syrup Average Price by Manufacturers (2021-2026)
- 3.5 Global DXM and Codeine Syrup Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of DXM and Codeine Syrup, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of DXM and Codeine Syrup, Product Type & Application
- 3.8 Global Manufacturers of DXM and Codeine Syrup, Established Date
- 3.9 Global DXM and Codeine Syrup Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Atley Pharmaceuticals
- 4.1.1 Atley Pharmaceuticals Company Information
- 4.1.2 Atley Pharmaceuticals Business Overview
- 4.1.3 Atley Pharmaceuticals DXM and Codeine Syrup Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Atley Pharmaceuticals DXM and Codeine Syrup Product Portfolio
- 4.1.5 Atley Pharmaceuticals Recent Developments
- 4.2 Vertical Pharmaceuticals
- 4.2.1 Vertical Pharmaceuticals Company Information
- 4.2.2 Vertical Pharmaceuticals Business Overview
- 4.2.3 Vertical Pharmaceuticals DXM and Codeine Syrup Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Vertical Pharmaceuticals DXM and Codeine Syrup Product Portfolio
- 4.2.5 Vertical Pharmaceuticals Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer DXM and Codeine Syrup Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer DXM and Codeine Syrup Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck DXM and Codeine Syrup Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck DXM and Codeine Syrup Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis DXM and Codeine Syrup Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis DXM and Codeine Syrup Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Johnson & Johnson
- 4.6.1 Johnson & Johnson Company Information
- 4.6.2 Johnson & Johnson Business Overview
- 4.6.3 Johnson & Johnson DXM and Codeine Syrup Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Johnson & Johnson DXM and Codeine Syrup Product Portfolio
- 4.6.5 Johnson & Johnson Recent Developments
5 Global DXM and Codeine Syrup Market Scenario by Region
- 5.1 Global DXM and Codeine Syrup Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global DXM and Codeine Syrup Sales by Region: 2021-2032
- 5.2.1 Global DXM and Codeine Syrup Sales by Region: 2021-2026
- 5.2.2 Global DXM and Codeine Syrup Sales by Region: 2027-2032
- 5.3 Global DXM and Codeine Syrup Revenue by Region: 2021-2032
- 5.3.1 Global DXM and Codeine Syrup Revenue by Region: 2021-2026
- 5.3.2 Global DXM and Codeine Syrup Revenue by Region: 2027-2032
- 5.4 North America DXM and Codeine Syrup Market Facts & Figures by Country
- 5.4.1 North America DXM and Codeine Syrup Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America DXM and Codeine Syrup Sales by Country (2021-2032)
- 5.4.3 North America DXM and Codeine Syrup Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe DXM and Codeine Syrup Market Facts & Figures by Country
- 5.5.1 Europe DXM and Codeine Syrup Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe DXM and Codeine Syrup Sales by Country (2021-2032)
- 5.5.3 Europe DXM and Codeine Syrup Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific DXM and Codeine Syrup Market Facts & Figures by Country
- 5.6.1 Asia Pacific DXM and Codeine Syrup Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific DXM and Codeine Syrup Sales by Country (2021-2032)
- 5.6.3 Asia Pacific DXM and Codeine Syrup Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America DXM and Codeine Syrup Market Facts & Figures by Country
- 5.7.1 South America DXM and Codeine Syrup Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America DXM and Codeine Syrup Sales by Country (2021-2032)
- 5.7.3 South America DXM and Codeine Syrup Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa DXM and Codeine Syrup Market Facts & Figures by Country
- 5.8.1 Middle East and Africa DXM and Codeine Syrup Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa DXM and Codeine Syrup Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa DXM and Codeine Syrup Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global DXM and Codeine Syrup Sales by Type (2021-2032)
- 6.1.1 Global DXM and Codeine Syrup Sales by Type (2021-2032) & (k units)
- 6.1.2 Global DXM and Codeine Syrup Sales Market Share by Type (2021-2032)
- 6.2 Global DXM and Codeine Syrup Revenue by Type (2021-2032)
- 6.2.1 Global DXM and Codeine Syrup Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global DXM and Codeine Syrup Revenue Market Share by Type (2021-2032)
- 6.3 Global DXM and Codeine Syrup Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global DXM and Codeine Syrup Sales by Application (2021-2032)
- 7.1.1 Global DXM and Codeine Syrup Sales by Application (2021-2032) & (k units)
- 7.1.2 Global DXM and Codeine Syrup Sales Market Share by Application (2021-2032)
- 7.2 Global DXM and Codeine Syrup Revenue by Application (2021-2032)
- 7.2.1 Global DXM and Codeine Syrup Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global DXM and Codeine Syrup Revenue Market Share by Application (2021-2032)
- 7.3 Global DXM and Codeine Syrup Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 DXM and Codeine Syrup Value Chain Analysis
- 8.1.1 DXM and Codeine Syrup Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 DXM and Codeine Syrup Production Mode & Process
- 8.2 DXM and Codeine Syrup Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 DXM and Codeine Syrup Distributors
- 8.2.3 DXM and Codeine Syrup Customers
9 Global DXM and Codeine Syrup Analyzing Market Dynamics
- 9.1 DXM and Codeine Syrup Industry Trends
- 9.2 DXM and Codeine Syrup Industry Drivers
- 9.3 DXM and Codeine Syrup Industry Opportunities and Challenges
- 9.4 DXM and Codeine Syrup Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst